- $9.25bn
- $10.38bn
- $5.19bn
- 89
- 65
- 31
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,624 | 2,718 | 3,486 | 5,009 | 5,195 |
Cost of Revenue | |||||
Gross Profit | 681 | 746 | 974 | 1,487 | 1,604 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,335 | 2,363 | 3,024 | 4,212 | 4,316 |
Operating Profit | 290 | 355 | 463 | 797 | 879 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 254 | 323 | 433 | 742 | 825 |
Provision for Income Taxes | |||||
Net Income After Taxes | 191 | 247 | 324 | 556 | 614 |
Net Income Before Extraordinary Items | |||||
Net Income | 191 | 247 | 324 | 556 | 614 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 191 | 247 | 324 | 556 | 614 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.56 | 7.44 | 10.4 | 17.2 | 19.7 |